Studies have shown that LOX mRNA level was increased in various cancer types, including head and neck squamous cell carcinoma, and breast and prostate cancers (Kirschmann et al., 2002; Lapointe et al., 2004; Erler et al., 2006). Here, LOX is linked to head and neck squamous cell carcinoma.